Vasculox, Inc.
Records under this name other than the patents Vasculox, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 5 of 5 · Back to Vasculox, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,292,834 | Therapeutic CD47 antibodies Lapsed on the fee record Ended Apr 5, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2026 | From the USPTO record |
| US 9,518,116 | Therapeutic CD47 antibodies Lapsed on the fee record Ended Dec 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2024 | From the USPTO record |
| US 9,518,117 | Therapeutic CD47 antibodies Lapsed on the fee record Ended Dec 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2024 | From the USPTO record |
| US 10,676,524 | Therapeutic CD47 antibodies Lapsed on the fee record Ended Jun 9, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2024 | From the USPTO record |
| US 10,669,336 | Therapeutic CD47 antibodies Lapsed on the fee record Ended Jun 2, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2024 | From the USPTO record |